Ipsen to buy Memo Therapeutics for over $799 million
Investing.com Gold reports: Ipsen to buy Memo Therapeutics for over $799 million. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Ipsen to buy Memo Therapeutics for over $799 million. Full body text was unavailable at ingest time, so this brief is based on headline context.